key: cord-1001277-qujp0qpi
authors: Abobaker, Anis; Nagib, Taha; Alsoufi, Ahmed
title: The impact of certain genetic variants (single nucleotide polymorphisms) on incidence and severity of COVID‐19
date: 2021-01-12
journal: J Gene Med
DOI: 10.1002/jgm.3310
sha: 01442294d87bd94a0d4b0b0a1a029cf51107e62f
doc_id: 1001277
cord_uid: qujp0qpi

nan

Dear Editor, The incidence of novel coronavirus disease (COVID-19) varies considerably between different countries and continents and, so far, there has been no clear explanation for this observation. Furthermore, there is a variation in disease severity, ranging from asymptomatic carriers and mild symptoms to a life-threatening illness that requires intensive care unit (ICU) admission and mechanical ventilation. 1 A few factors are linked to the severity of COVID-19, such as old age, multiple comorbidities and male sex. 2 However, severe illness has been observed in patients who do not have the above risk factors. Therefore, we would like to review whether genetic factors such as single nucleotide polymorphisms (SNPs) in certain genes could possibly have an impact on the variation in disease incidence and severity.

Novel coronavirus (SARS-CoV-2) enters the cells by binding with angiotensin-converting enzyme 2 (ACE2) receptor. This binding is facilitated by the activity of a human enzyme: type 2 transmembrane serine protease (TMPRSS2). 3 Therefore, SNPs in ACE2 gene that alter the structure of the proteins or the rate of ACE2 receptor expression could have an impact on the susceptibility to and severity of COVID-19. Calcagnile et al. 4 identified two ACE2 SNPs that affect the affinity of SARS-CoV-2 viral proteins to bind with ACE2 receptors. S19P SNP (rs73635825), which is common in Africans, decreases the binding affinity, whereas K26R SNP (rs1299103394), which is common in Europeans, increases the binding affinity. 4 Although this is not sufficient evidence, these findings could explain the considerable low incidence of COVID-19 in Africa compared to Europe. Hussain et al. 5 found that S19P variant has the lowest binding affinity to SARS-CoV-2 viral proteins compared to other ACE2 polymorphisms. They also found that S19P and E329G ACE2 SNP (rs143936283) increase the resistance to SARS-CoV-2 infection. 5 Moreover, Wooster et al. 6 identified that six SNPs in the ACE2 gene region that increase the expression level of ACE2 receptors are significantly associated with a higher risk of hospitalisation in patients with COVID-19. Interestingly, the expression of the TMPRSS2 gene increases in response to androgen hormone levels. 2 This could explain the higher risk of disease severity in male compared to female patients. There are three SNPs in TMPRSS2 (rs2070788, rs9974589 and rs7364083) that increase the expression level of TMPRSS2 and could be linked with an increased susceptibility to and severity of COVID-19. 2 The frequency of these genetic variants is significantly higher in Europeans. 2 The excessive release of cytokines (known as a cytokine storm) in response to COVID-19 infection is the main pathological mechanism leading to lung injury and multi-organ damage. 3 SNPs in cytokine genes are linked to a higher chance of development of sepsis and septic shock. 7 Tumour necrosis factor (TNF)-2, a polymorphism in the promotor region of the TNF-α gene, can result in higher TNF-α levels, which subsequently increases the chance of development of septic shock and death. 8 Another polymorphism in the promotor region of TNF-α gene (G-308) increases the incidence and severity of infection in patients with COVID-19. 9 Furthermore, TNF-α promotor region variants were found to increase the risk of femoral head necrosis in patients who recovered from SARS-CoV infection. 10 16 These mutations suppressed the production of interferon, which subsequently weakened the immune response against the viral infection and predisposed to severe disease. 16 In addition to the TMPRSS2 gene, the expression of ACE2 gene is also androgen dependent. 17 It has been proposed that the length of the CAG repeat polymorphism in the androgen receptor is inversely linked with disease severity in COVID-19. 17 So far, this link has not been established, and McCoy et al. 17 are planning to conduct a clinical study to test this possibility. Indeed, four genetic variants identified in certain protease genes that alter the structure and function of the encoded protease proteins, which consequently cleave SARS-CoV-2 protein to facilitate viral cell entry, could be protective against and decrease the severity of COVID-19 infection. 18 In conclusion, SNPs in ACE2, TMPRSS2, cytokines, TLR-7, androgen receptor and protease genes could have a significant impact on incidence and severity of COVID-19. Performing genetic analysis in patients with COVID-19 to detect these variants could help in risk stratification of patients to plan their management accordingly.

Clinical characteristics of coronavirus disease 2019 in China

ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy

Pharmacologic treatments for coronavirus disease 2019 (COVID-19)

ACE2 polymorphisms and individual susceptibility to SARS-CoV-2 infection: insights from an in silico study

Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein

Polymorphisms in the ACE2 locus associate with severity of COVID-19 infection. medRxiv Preprint

Cytokine storm and sepsis disease pathogenesis

Association of TNF2, a TNF-α promoter polymorphism, with septic shock susceptibility and mortality

Association of TNF-α G-308 a promoter polymorphism with the course and outcome of COVID-19 patients

Roles of TNF-α gene polymorphisms in the occurrence and progress of SARS-Cov infection: a case-control study

Nasopharyngeal shedding of severe acute respiratory syndrome--associated coronavirus is associated with genetic polymorphisms

A functional synonymous coding variant in theIL1RNGene is associated with survival in septic shock

Association of IL-10 polymorphism with severity of illness in community acquired pneumonia

Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia

Interleukin-6 as a potential biomarker of COVID-19 progression

Presence of genetic variants among young men with severe COVID-19

Racial variations in COVID-19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are antiandrogens a potential treatment for COVID-19?

Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection